WO2015179840A1 - Combination, composition, and method of administering the combination or composition to animals - Google Patents

Combination, composition, and method of administering the combination or composition to animals Download PDF

Info

Publication number
WO2015179840A1
WO2015179840A1 PCT/US2015/032301 US2015032301W WO2015179840A1 WO 2015179840 A1 WO2015179840 A1 WO 2015179840A1 US 2015032301 W US2015032301 W US 2015032301W WO 2015179840 A1 WO2015179840 A1 WO 2015179840A1
Authority
WO
WIPO (PCT)
Prior art keywords
ppm
composition
combination
animal
quillaja saponaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2015/032301
Other languages
English (en)
French (fr)
Inventor
Kenneth W. BAFUNDO
A. Bruce JOHNSON
David CALABOTTA
Wendell KNEHANS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phibro Animal Health Corp
Original Assignee
Phibro Animal Health Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CN201580035572.6A priority Critical patent/CN106659787A/zh
Priority to BR112016027335-4A priority patent/BR112016027335B1/pt
Priority to AU2015263877A priority patent/AU2015263877B2/en
Priority to RU2016149801A priority patent/RU2707076C2/ru
Priority to CA2949965A priority patent/CA2949965A1/en
Priority to KR1020167035990A priority patent/KR20170008850A/ko
Priority to MX2016015326A priority patent/MX381845B/es
Priority to EP15727805.2A priority patent/EP3145522B1/en
Priority to JP2017514395A priority patent/JP6869177B2/ja
Priority to PL15727805T priority patent/PL3145522T3/pl
Priority to ES15727805T priority patent/ES2856207T3/es
Priority to MYPI2016704330A priority patent/MY181854A/en
Application filed by Phibro Animal Health Corp filed Critical Phibro Animal Health Corp
Publication of WO2015179840A1 publication Critical patent/WO2015179840A1/en
Priority to IL249061A priority patent/IL249061B/en
Priority to US15/359,342 priority patent/US10413581B2/en
Priority to PH12016502323A priority patent/PH12016502323A1/en
Priority to ZA2016/08077A priority patent/ZA201608077B/en
Anticipated expiration legal-status Critical
Priority to US16/525,383 priority patent/US10912810B2/en
Priority to US17/132,467 priority patent/US12201666B2/en
Priority to AU2021202307A priority patent/AU2021202307B2/en
Priority to US19/020,701 priority patent/US20250152654A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Definitions

  • FIG. 2 is a graph of average weight (kg) and adjusted feed conversion obtained from birds fed for 28-42 days with bird feed (Treatment Group 1), and bird feed comprising 125 ppm of a composition embodiment (Treatment Group 2), 250 ppm of a composition embodiment (Treatment
  • FIG. 39 is a graph of adjusted feed conversion illustrating the effects of a composition embodiment on birds vaccinated with a coccidiosis vaccine at birth wherein the results illustrated are for birds that were not fed the composition embodiment (left bar) and for birds that were fed the composition for different time periods (right bar); the results were measured at day 28.
  • Suitable anticoccidial agents include, but are not limited to, ionophores and chemical anticoccidial products.
  • Ionophores can include, but are not limited to, Monensin, Salinomycin, Lasalocid, Narasin, Maduramicin, Semduramicin, Laidlomycin, or combinations thereof.
  • antimicrobial or antibiotic used is within the amounts stated below but may depend on the particular antimicrobial or antibiotic used as will be understood by a person of ordinary skill in the art. In an independent embodiment, the amount of the antibiotic or
  • the amount of the antimicrobial or antibiotic that is included in the composition can range from at least 1 g/ton of feed to 230 g/ton of feed (or at least 1.1 ppm to 256 ppm), such as at least 1 g/ton of feed to 220 g/ton of feed (or at least 1.1 ppm to 243 ppm), at least 1 g/ton of feed to 100 g/ton of feed (or at least 1.1 ppm to 110 ppm), at least 1 g/ton of feed to 50 g/ton of feed (or at least 1.1 ppm to 55 ppm), or at least 1 g/ton of feed to 10 g/ton of feed (or at least 1.1 ppm to 11 ppm).
  • Particular antimicrobials or antibiotics that can be used, and dosage amounts of such antimicrobials and antibiotics include, but are not limited to, the following:
  • the amount of vaccine used is a therapeutically effective amount ranging from greater than 0 mL/animal to 1,000 mL/animal, or 0.25 mL/animal to 500 mL/animal, or 0.5 mL/animal to 150 mL/animal, or 1 mL/animal to 100 mL/animal, or 2 mL/animal to 50 mL/animal, or 3 mL/animal to 25 mL/animal, or 5 mL/animal to 15 mL/animal.
  • the amount of the composition comprising yucca, quillaja, or a combination thereof that can be administered to animals can be measured based on the amount of the composition per unit body weight of an animal, such as mg/kg BW/day and/or g/kg BW/day, wherein "BW" refers to body weight.
  • the first composition comprises Yucca schidigera, Quillaja saponaria and the composition is administered to avian.
  • the amount of the first composition can range from greater than 150 ppm to 5,000 ppm, such as at least 200 ppm to 5,000 ppm, such as at least 200 ppm to 500 ppm, or 250 ppm to 300 ppm of a composition comprising Yucca schidigera, Quillaja saponaria, or a combination thereof.
  • the composition comprising yucca, quillaja, or a combination thereof can be administered to aquaculture species.
  • the methods can comprise providing the aquaculture species an amount of the composition that ranges from greater than 0 ppm to 100,000 ppm, such as 100 ppm to 50,000 ppm, or 200 ppm to 25,000 ppm, or 300 ppm to 15,000 ppm, or 400 ppm to 5,000 ppm, or 500 ppm to 1,000 ppm.
  • the amount ranges from 300 ppm to 2,000 ppm, such as 300 ppm to 500 ppm.
  • the combination can comprise a first composition comprising Yucca schidigera and Quillaja saponaria, a second composition comprising an antimicrobial agent and/or an antibiotic, and a third composition comprising a vaccine.
  • a feedstuff also may be administered in such embodiments.
  • the combination of the first, second, and/or third compositions that is administered can be admixed with a feedstuff prior to administration to the animal, or the feedstuff may be administered before or after the combination of the first, second, and/or third compositions.
  • FIGS. 11-19 Results from this embodiment are illustrated in FIGS. 11-19.
  • broilers that were administered the vaccine alone did not show the low feed conversion rates that broilers administered with the Yucca schidigera and Quillaja saponaria composition and/or Virginiamycin.
  • FIGS. 11-13 also illustrate that broilers administered with a combination of the vaccine, the Yucca schidigera and Quillaja saponaria composition, and Virginiamycin exhibited the lowest feed conversion rates.
  • composition 250 ppm 1.5a 0.8a 0.4b 0.9b
  • E.A E. acervulina
  • E.M. E. maxima
  • E.T.” E. tenella
  • kits comprising administering a combination as disclosed herein to an animal at least once daily from day of age and for a time period sufficient to promote a beneficial health effect.
  • the combination comprises 200 ppm to 5,000 ppm of a first composition comprising Quillaja saponaria, Yucca schidigera, or a combination thereof; and a second composition comprising an antimicrobial agent, an antibiotic, an anticoccidial agent, or a combination thereof, and wherein the combination is administered to a chicken or turkey.
  • the first and second compositions are administered sequentially, in any order.
  • the method can further comprise administering the first composition and the second composition in combination with a feedstuff.
  • the combination is administered to a chicken or turkey and the feedstuff is provided in an amount ranging from at least 7 lbs to 10 lbs of a feedstuff per chicken or turkey.
  • the first composition, the second composition, and the feedstuff are administered substantially simultaneously.
  • the first composition, the second composition, and the feedstuff are administered sequentially, in any order.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PCT/US2015/032301 2014-05-23 2015-05-22 Combination, composition, and method of administering the combination or composition to animals Ceased WO2015179840A1 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
ES15727805T ES2856207T3 (es) 2014-05-23 2015-05-22 Combinación, composición y método de administración de la combinación o composición a los animales
AU2015263877A AU2015263877B2 (en) 2014-05-23 2015-05-22 Combination, composition, and method of administering the combination or composition to animals
RU2016149801A RU2707076C2 (ru) 2014-05-23 2015-05-22 Комбинация, композиция и способ введения комбинации или композиции животным
CA2949965A CA2949965A1 (en) 2014-05-23 2015-05-22 Combination, composition, and method of administering the combination or composition to animals
KR1020167035990A KR20170008850A (ko) 2014-05-23 2015-05-22 배합물, 조성물, 및 배합물 또는 조성물의 동물로의 투여 방법
BR112016027335-4A BR112016027335B1 (pt) 2014-05-23 2015-05-22 combinação, uso desta, método para produzir a referida combinação e composição formulada para administração a um animal
EP15727805.2A EP3145522B1 (en) 2014-05-23 2015-05-22 Combination, composition, and method of administering the combination or composition to animals
JP2017514395A JP6869177B2 (ja) 2014-05-23 2015-05-22 組み合わせ、組成物及び動物に組み合わせ又は組成物を投与する方法
PL15727805T PL3145522T3 (pl) 2014-05-23 2015-05-22 Kombinacja, kompozycja i sposób podawania kombinacji lub kompozycji zwierzętom
MYPI2016704330A MY181854A (en) 2014-05-23 2015-05-22 Combination, composition, and method of administering the combination or composition to animals
MX2016015326A MX381845B (es) 2014-05-23 2015-05-22 Combinación, composición y método de administración de la combinación o composición a animales.
CN201580035572.6A CN106659787A (zh) 2014-05-23 2015-05-22 组合、组合物及向动物施用所述组合或组合物的方法
IL249061A IL249061B (en) 2014-05-23 2016-11-20 Combination, composition, and method of administering the combination or composition to animals
US15/359,342 US10413581B2 (en) 2014-05-23 2016-11-22 Combination, composition, and method of administering the combination or composition to animals
PH12016502323A PH12016502323A1 (en) 2014-05-23 2016-11-22 Combination, composition, and method of administering the combination or composition to animals
ZA2016/08077A ZA201608077B (en) 2014-05-23 2016-11-22 Combination, composition, and method of administering the combination or composition to animals
US16/525,383 US10912810B2 (en) 2014-05-23 2019-07-29 Combination, composition, and method of administering the combination or composition to animals
US17/132,467 US12201666B2 (en) 2014-05-23 2020-12-23 Combination, composition, and method of administering the combination or composition to animals
AU2021202307A AU2021202307B2 (en) 2014-05-23 2021-04-16 Combination, composition, and method of administering the combination or composition to animals
US19/020,701 US20250152654A1 (en) 2014-05-23 2025-01-14 Combination, composition, and method of administering the combination or composition to animals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462002527P 2014-05-23 2014-05-23
US62/002,527 2014-05-23

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/359,342 Continuation-In-Part US10413581B2 (en) 2014-05-23 2016-11-22 Combination, composition, and method of administering the combination or composition to animals

Publications (1)

Publication Number Publication Date
WO2015179840A1 true WO2015179840A1 (en) 2015-11-26

Family

ID=53366304

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/032301 Ceased WO2015179840A1 (en) 2014-05-23 2015-05-22 Combination, composition, and method of administering the combination or composition to animals

Country Status (18)

Country Link
US (4) US10413581B2 (https=)
EP (1) EP3145522B1 (https=)
JP (2) JP6869177B2 (https=)
KR (1) KR20170008850A (https=)
CN (1) CN106659787A (https=)
AU (2) AU2015263877B2 (https=)
BR (1) BR112016027335B1 (https=)
CA (1) CA2949965A1 (https=)
CL (1) CL2016002992A1 (https=)
ES (1) ES2856207T3 (https=)
IL (1) IL249061B (https=)
MX (1) MX381845B (https=)
MY (1) MY181854A (https=)
PH (1) PH12016502323A1 (https=)
PL (1) PL3145522T3 (https=)
RU (1) RU2707076C2 (https=)
WO (1) WO2015179840A1 (https=)
ZA (1) ZA201608077B (https=)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017044832A1 (en) * 2015-09-09 2017-03-16 Omnigen Research, Llc A composition and/or combination for aquaculture
US10045693B2 (en) 2012-10-01 2018-08-14 Kabushiki Kaisha Topcon Ophthalmologic observation apparatus
US10307426B2 (en) 2017-05-22 2019-06-04 Genentech, Inc. Therapeutic compounds and compositions, and methods of use thereof
US20200359653A1 (en) * 2018-01-24 2020-11-19 Omnigen Research, Llc Bacillus combination for administration to animals
US10987393B2 (en) 2016-07-29 2021-04-27 Saponin Research Center S.A. Method for preventing and controlling bacterial infections in salmonid fish using Quillaja saponaria extracts
US10987392B2 (en) 2016-07-29 2021-04-27 Saponin Research Center S.A. Method for preventing and controlling viral infections in salmonid fish using Quillaja saponaria extracts
WO2021258055A1 (en) * 2020-06-19 2021-12-23 Kimberly-Clark Worldwide, Inc. Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
WO2021258056A1 (en) * 2020-06-19 2021-12-23 Kimberly-Clark Worldwide, Inc. Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
US20220030913A1 (en) * 2020-08-03 2022-02-03 Hoxie Feedyard, LLC Supplement for livestock
WO2023281331A1 (es) * 2021-07-07 2023-01-12 Biovet S.A. Aditivo para animales que contiene saponinas, compuestos fenólicos y p-cimenol, y procedimiento para su obtención
WO2023163884A1 (en) * 2022-02-22 2023-08-31 Phibro Animal Health Corporation Liquid formulation comprising yucca and quillaja for administration to animals
EP4218419A4 (en) * 2020-09-25 2024-10-23 CJ Cheiljedang Corporation ANTICOCCIDIAL COMPOSITION COMPRISING A STILBENE-BASED COMPOUND, AS WELL AS ITS USE

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11238056B2 (en) 2013-10-28 2022-02-01 Microsoft Technology Licensing, Llc Enhancing search results with social labels
US11645289B2 (en) 2014-02-04 2023-05-09 Microsoft Technology Licensing, Llc Ranking enterprise graph queries
WO2015123456A1 (en) 2014-02-12 2015-08-20 OmniGen Research, L.L.C. Composition and method for promoting reduction of heat stress in animals
US9870432B2 (en) 2014-02-24 2018-01-16 Microsoft Technology Licensing, Llc Persisted enterprise graph queries
US11657060B2 (en) 2014-02-27 2023-05-23 Microsoft Technology Licensing, Llc Utilizing interactivity signals to generate relationships and promote content
US10757201B2 (en) 2014-03-01 2020-08-25 Microsoft Technology Licensing, Llc Document and content feed
US10394827B2 (en) 2014-03-03 2019-08-27 Microsoft Technology Licensing, Llc Discovering enterprise content based on implicit and explicit signals
US10255563B2 (en) 2014-03-03 2019-04-09 Microsoft Technology Licensing, Llc Aggregating enterprise graph content around user-generated topics
US10169457B2 (en) 2014-03-03 2019-01-01 Microsoft Technology Licensing, Llc Displaying and posting aggregated social activity on a piece of enterprise content
AU2015263877B2 (en) 2014-05-23 2021-01-21 Desert King International Llc Combination, composition, and method of administering the combination or composition to animals
US10061826B2 (en) * 2014-09-05 2018-08-28 Microsoft Technology Licensing, Llc. Distant content discovery
CN107535727A (zh) * 2017-10-29 2018-01-05 镇江龙润生态农业发展有限公司 一种含有中草药的用于肉鸡无抗生态养殖的饲料添加剂
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用
US20240148671A1 (en) * 2021-03-10 2024-05-09 Cornell University Methods for improving poultry health
CN113057141A (zh) * 2021-05-10 2021-07-02 天津农学院 一种提高蛋鸡蛋黄中卵磷脂含量的饲喂方法
WO2024156767A1 (en) * 2023-01-25 2024-08-02 Nutreco Nederland B.V. Method of feeding (pre)ruminants
WO2025085377A1 (en) * 2023-10-16 2025-04-24 Zoetis Services Llc Use of zoalene in livestock

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067963A1 (en) * 2001-02-27 2002-09-06 Celltechs Co., Ltd. Compositions for lowering serum cholesterol level
US20060051365A1 (en) * 2002-07-10 2006-03-09 Gorenflot Andre F Immunogenic composition
US20080274211A1 (en) * 2004-06-16 2008-11-06 Sartec Corporation Methods and Compositions for Controlling Micororganism Populations in the Digestive System of Animals

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07107923A (ja) 1993-10-13 1995-04-25 Taiyo Kagaku Co Ltd 飼料用組成物
JP3422834B2 (ja) * 1994-02-09 2003-06-30 日本農産工業株式会社 飼料添加剤
JP3623994B2 (ja) 1994-11-05 2005-02-23 太陽化学株式会社 甲殻類の感染症抑制飼料組成物
JPH09224585A (ja) * 1996-02-26 1997-09-02 F Hoffmann La Roche Ag ニワトリにおける成長促進
TWI223595B (en) 1999-09-07 2004-11-11 Distributors Proc Inc Steroidal sapogenins for the control of coccidiosis in animals
DE19952360A1 (de) 1999-10-30 2001-05-17 Becker Klaus Wolfgang Verwendung von Saponinen und/oder Saponin-Derivaten als Wirkstoff bei der Aufzucht und Mast von Fischen und Krustentieren, deren Einsatz als Futtermittelzusatz sowie Futtermittel, enthaltend diese Futtermittelzusätze
DK1361801T3 (da) 2001-01-08 2007-10-08 Pathway Intermediates Ltd Autoinducerforbindelser og deres anvendelser
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
DK2094278T3 (en) * 2006-11-20 2017-07-24 Duecom USE OF LIPID-CONTAINING PARTICLES INCLUDING QUILLAJA SAPONINS FOR CANCER TREATMENT
TW201010719A (en) * 2008-08-19 2010-03-16 Wyeth Corp Immunological composition
US20100150958A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. Methods and Compositions for Use of a Coccidiosis Vaccine
ES2386474B1 (es) * 2011-01-21 2013-07-09 Norel, Sa Aditivos para alimentación animal.
AU2015263877B2 (en) * 2014-05-23 2021-01-21 Desert King International Llc Combination, composition, and method of administering the combination or composition to animals
WO2019147799A1 (en) * 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067963A1 (en) * 2001-02-27 2002-09-06 Celltechs Co., Ltd. Compositions for lowering serum cholesterol level
US20060051365A1 (en) * 2002-07-10 2006-03-09 Gorenflot Andre F Immunogenic composition
US20080274211A1 (en) * 2004-06-16 2008-11-06 Sartec Corporation Methods and Compositions for Controlling Micororganism Populations in the Digestive System of Animals

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
AL-BAR A ET AL: "Effect of dietary Yucca shidegria extract (Deodorase) on environmental ammonia and growth performance of chickens and rabbits", JOURNAL OF ANIMAL SCIENCE, AMERICAN SOCIETY OF ANIMAL SCIENCE, US, vol. 71, no. Suppl. 1, 1 January 1993 (1993-01-01), pages 114, XP009185097, ISSN: 0021-8812 *
CHEEKE P R: "Actual and potential applications of Yucca schidigera and Quillaja saponaria saponins in human and animal nutrition", JOURNAL OF ANIMAL SCIENCE, 17 June 2009 (2009-06-17), pages 1 - 10, XP002532795, ISSN: 0021-8812 *
JOHNSTON N L ET AL: "EVALUATION OF DSS-40 YUCCA SAPONIN ON BROILER PERFORMANCE", POULTRY SCIENCE, CHAMPAIGN, IL, US, vol. 59, no. 7, 1 January 1980 (1980-01-01), pages 1625, XP009185096, ISSN: 0032-5791 *
R Z ABBAS ET AL: "Botanicals: an alternative approach for the control of avian coccidiosis", WORLD S POULTRY SCIENCE JOURNAL., vol. 68, no. 2, 1 June 2012 (2012-06-01), GB, pages 203 - 215, XP055198874, ISSN: 0043-9339, DOI: 10.1017/S0043933912000268 *
SHERIF M HASSAN ET AL: "Hemolytic and Antimicrobial Activities Differ Among Saponin-rich Extracts From Guar, Quillaja, Yucca, and Soybean", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 162, no. 4, 1 October 2010 (2010-10-01), United States, pages 1008 - 1017, XP055198875, ISSN: 0273-2289, DOI: 10.1007/s12010-009-8838-y *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10045693B2 (en) 2012-10-01 2018-08-14 Kabushiki Kaisha Topcon Ophthalmologic observation apparatus
US11627749B2 (en) 2015-09-09 2023-04-18 Omnigen Research, Llc Composition and/or combination for aquaculture
WO2017044832A1 (en) * 2015-09-09 2017-03-16 Omnigen Research, Llc A composition and/or combination for aquaculture
US10987393B2 (en) 2016-07-29 2021-04-27 Saponin Research Center S.A. Method for preventing and controlling bacterial infections in salmonid fish using Quillaja saponaria extracts
US10987392B2 (en) 2016-07-29 2021-04-27 Saponin Research Center S.A. Method for preventing and controlling viral infections in salmonid fish using Quillaja saponaria extracts
US10307426B2 (en) 2017-05-22 2019-06-04 Genentech, Inc. Therapeutic compounds and compositions, and methods of use thereof
US20200359653A1 (en) * 2018-01-24 2020-11-19 Omnigen Research, Llc Bacillus combination for administration to animals
US12458043B2 (en) 2018-01-24 2025-11-04 Omnigen Research, Llc Bacillus combination for administration to animals
US11653674B2 (en) * 2018-01-24 2023-05-23 Omnigen Research, Llc Bacillus combination for administration to animals
EP4167759A4 (en) * 2020-06-19 2024-08-28 Kimberly-Clark Worldwide, Inc. SAPONIN-CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS
EP4168017A4 (en) * 2020-06-19 2024-08-07 Kimberly-Clark Worldwide, Inc. Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
WO2021258056A1 (en) * 2020-06-19 2021-12-23 Kimberly-Clark Worldwide, Inc. Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
EP4167760A4 (en) * 2020-06-19 2024-08-28 Kimberly-Clark Worldwide, Inc. ANIMAL FEED COMPOSITION FOR REDUCING AMMONIA PRODUCTION
WO2021258055A1 (en) * 2020-06-19 2021-12-23 Kimberly-Clark Worldwide, Inc. Saponin containing extracts prepared from hesperaloe useful in the treatment of non-human animals
US12576098B2 (en) 2020-06-19 2026-03-17 Kimberly-Clark Worldwide, Inc. Saponin containing extracts prepared from Hesperaloe useful in the treatment of non-human animals
US20220030913A1 (en) * 2020-08-03 2022-02-03 Hoxie Feedyard, LLC Supplement for livestock
EP4218419A4 (en) * 2020-09-25 2024-10-23 CJ Cheiljedang Corporation ANTICOCCIDIAL COMPOSITION COMPRISING A STILBENE-BASED COMPOUND, AS WELL AS ITS USE
ES2932416A1 (es) * 2021-07-07 2023-01-18 Biovet S A Aditivo para animales que contiene saponinas, compuestos fenolicos y p-cimenol, y procedimiento para su obtencion
WO2023281331A1 (es) * 2021-07-07 2023-01-12 Biovet S.A. Aditivo para animales que contiene saponinas, compuestos fenólicos y p-cimenol, y procedimiento para su obtención
WO2023163884A1 (en) * 2022-02-22 2023-08-31 Phibro Animal Health Corporation Liquid formulation comprising yucca and quillaja for administration to animals

Also Published As

Publication number Publication date
JP2017517570A (ja) 2017-06-29
AU2021202307A1 (en) 2021-05-13
AU2015263877B2 (en) 2021-01-21
US20210113647A1 (en) 2021-04-22
MY181854A (en) 2021-01-11
ES2856207T3 (es) 2021-09-27
PH12016502323A1 (en) 2017-02-06
CN106659787A (zh) 2017-05-10
ZA201608077B (en) 2020-01-29
MX2016015326A (es) 2017-05-30
MX381845B (es) 2025-03-13
US10912810B2 (en) 2021-02-09
CA2949965A1 (en) 2015-11-26
PL3145522T3 (pl) 2021-06-14
JP2020090502A (ja) 2020-06-11
US20170072002A1 (en) 2017-03-16
AU2021202307B2 (en) 2022-06-30
US12201666B2 (en) 2025-01-21
US10413581B2 (en) 2019-09-17
RU2016149801A (ru) 2018-06-25
AU2015263877A1 (en) 2017-01-12
IL249061A0 (en) 2017-01-31
KR20170008850A (ko) 2017-01-24
RU2707076C2 (ru) 2019-11-22
RU2016149801A3 (https=) 2018-11-14
CL2016002992A1 (es) 2017-05-19
EP3145522A1 (en) 2017-03-29
US20190350998A1 (en) 2019-11-21
JP6869177B2 (ja) 2021-05-12
IL249061B (en) 2020-05-31
EP3145522B1 (en) 2020-12-23
BR112016027335B1 (pt) 2021-06-08
US20250152654A1 (en) 2025-05-15

Similar Documents

Publication Publication Date Title
AU2021202307B2 (en) Combination, composition, and method of administering the combination or composition to animals
US10660930B2 (en) Combination and/or comprising bacillus, and yucca, quillaja, or both and a method for using and making
WO2018049243A1 (en) Feed additive comprising allicin
US20170106027A1 (en) Compositions and methods of improving performance and intestinal health of poultry
JP2001151675A (ja) コクシジウム症の予防および／または治療用飼料
PT1420804E (pt) Métodos e composições para o controlo da coccidiose
CN115776896A (zh) 通过动物饲料对球虫病预防和治疗的正潜伏期效应
Herrero-Encinas et al. Response of broiler chickens fed diets supplemented with a bioactive olive pomace extract from Olea europaea to an experimental coccidial vaccine challenge
Girdhar et al. Dietary putrescine (1, 4-diaminobutane) influences recovery of turkey poults challenged with a mixed coccidial infection
US4861758A (en) Coccidiocidal compositions
US8992999B2 (en) Methods and compositions for controlling parasitic infections of animals
Galyen et al. Effects of bambermycin with amprolium or monensin on beef cattle growth performance, coccidia infection, and bovine respiratory disease morbidity during receiving
EP1768491B1 (en) Composition and its use for controlling protozoal infections of animals
Gautier Coccidiosis vaccination and nutrient utilization in broiler chickens
El Iraqi et al. Evaluation of new biological product and salinomycin anticoccidial on performance, behaviour, and Eimeria count in broiler chickens
HK1102739B (en) Composition and its use for controlling protozoal infections of animals

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15727805

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 249061

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2949965

Country of ref document: CA

Ref document number: 2017514395

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 122020015044

Country of ref document: BR

Ref document number: 12016502323

Country of ref document: PH

Ref document number: MX/A/2016/015326

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2015727805

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015727805

Country of ref document: EP

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112016027335

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 20167035990

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2016149801

Country of ref document: RU

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2015263877

Country of ref document: AU

Date of ref document: 20150522

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112016027335

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20161122